Hemopexin Antibody [Dylight 680]
Novus Biologicals, part of Bio-Techne | Catalog # AF7007Y
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Immunohistochemistry, Western Blot
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse Hemopexin
Ser24-Gln460 (His30Asn)
Accession # Q91X72
Ser24-Gln460 (His30Asn)
Accession # Q91X72
Specificity
Detects mouse Hemopexin in direct ELISAs and Western blots. In direct ELISAs, approximately 45% cross-reactivity with recombinant human Hemopexin is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for Hemopexin Antibody [Dylight 680]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Hemopexin
Alternate Names
Beta-1B-glycoprotein, HPX
Gene Symbol
HPX
Additional Hemopexin Products
Product Documents for Hemopexin Antibody [Dylight 680]
Product Specific Notices for Hemopexin Antibody [Dylight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...